Results 11 to 20 of about 25,429 (227)

Carbapenem-ResistantAcinetobacter baumannii [PDF]

Korean Journal of Clinical Microbiology, 2012
Clinical isolates of Acinetobacter spp. in Korea exhibit higher antimicrobial resistance rates than in foreign countries and frequently show multi-drug resistance. Approximately 67% (272/405) of Acinetobacter baumannii isolates collected from 19 hospitals in Korea in 2008 exhibited intermediate susceptibility or resistance to imipenem and/or meropenem.
Il Kwon Bae, Seok Hoon Jeong, Kyungwon Lee   +2 more
openaire   +2 more sources

Molecular Identification of Carbapenem Resistance Acinetobacter baumannii causing Ventilator-Associated Pneumonia Isolated from Intensive Care Unit of Tertiary Care Hospital

Journal of Pure and Applied Microbiology
Ventilator-associated pneumonia (VAP) is a serious complication in critically ill patients, significantly increasing morbidity and mortality. One concerning organism behind VAP is Acinetobacter baumannii, a multidrug-resistant bacterium has ability to ...
Vijeta Sharma, Rajni Sharma, Aruna Vyas
doaj   +3 more sources

Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand

New Zealand Medical Journal, 2022
Carbapenem resistant Acinetobacter baumannii have limited treatment options and a propensity to cause hospital outbreaks. In recent years an increase in their detection has been observed in New Zealand. This study aimed to describe the molecular epidemiology of these isolates.This study utilised carbapenem resistant A.
Matthew R, Blakiston, Mark B, Schultz, Indira, Basu, Susan A, Ballard, Deborah, Williamson, Sally, Roberts   +5 more
core   +4 more sources

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii group in Taiwan

mSphere
Acinetobacter, particularly the Acinetobacter baumannii group, is a major cause of nosocomial infections, and carbapenem-resistant Acinetobacter spp. are important human pathogens. We collected 492 Acinetobacter spp.
Tran Lam Tu Quyen, Yu-Chia Hsieh, Shiao-Wen Li, Lii-Tzu Wu, Ya-Zhu Liu, Yi-Jiun Pan   +5 more
doaj   +2 more sources

Global spread of carbapenem-resistant Acinetobacter baumannii [PDF]

Journal of Antimicrobial Chemotherapy, 2009
We have investigated the molecular epidemiology and distribution of carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii worldwide isolates (North and Latin America, Europe, Asia, South Africa and Australia).MICs were determined by broth microdilution and Etest. The presence of carbapenemase-encoding genes was investigated by PCR.
Paul G, Higgins, Cathrin, Dammhayn, Meredith, Hackel, Harald, Seifert   +3 more
openaire   +3 more sources

A global view on carbapenem-resistant Acinetobacter baumannii

mBio, 2023
ABSTRACT To give an update on the molecular epidemiology and global distribution of carbapenemase encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated from 114 study centers in 47 countries in five world regions, Africa, Asia, Europe, Latin America, and North America, to ...
Carina Müller, Sandra Reuter, Julia Wille, Kyriaki Xanthopoulou, Danuta Stefanik, Hajo Grundmann, Paul G. Higgins, Harald Seifert   +7 more
openaire   +4 more sources

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology [PDF]

Clinical Microbiology and Infection, 2006
The increasing trend of carbapenem resistance in Acinetobacter baumannii worldwide is a concern since it limits drastically the range of therapeutic alternatives. Metallo-beta-lactamases (VIM, IMP, SIM) have been reported worldwide, especially in Asia and western Europe, and confer resistance to all beta-lactams except aztreonam.
Poirel, L., Nordmann, P.
openaire   +2 more sources

Insights on carbapenem-resistant Acinetobacter baumannii [PDF]

Acta Biologica Szegediensis, 2021
Acinetobacter baumannii (A. baumannii) is an important nosocomial pathogen, which may be a causative agent in a wide-range of human pathologies. Carbapenems are usually considered the last safe and effective choice of drugs for the treatment of Gram-negative infections. The emergence of carbapenem-resistant A.
Matthew Gavino Donadu, Stefania Zanetti, Ádám László Nagy, Ibrahim Barrak, Márió Gajdács   +4 more
openaire   +3 more sources

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii [PDF]

Frontiers in Microbiology, 2014
Acinetobacter baumannii is an opportunistic pathogen causing pneumonia, respiratory infections and urinary tract infections. The prevalence of this lethal pathogen increases gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a carbon source. Moreover it resists desiccation. Carbapenems, a β-lactam, are the most
Tiwari, Vishvanath, Tiwari, Monalisa
openaire   +3 more sources

Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, England [PDF]

, 2014
Background: Multidrug-resistant Acinetobacter baumannii commonly causes hospital outbreaks. However, within an outbreak, it can be difficult to identify the routes of cross-infection rapidly and accurately enough to inform infection control.
Chan, Jacqueline, Beryl Oppenheim, Chan, Jacqueline Z-M, Constantinidou, Chrystala, Bradley, Craig, Halachev, Mihail R, Pallen, Mark J, Pallen, Mark J., Nicola Cumley, Matthew Smith-Banks, Mihail R Halachev, Smith-Banks, Matthew, Halachev, Mihail R., Jacqueline Z-M Chan, Oppenheim, Beryl, Craig Bradley, Constantinidou, Chrystala I, Chrystala I Constantinidou, Cumley, Nicola, Mark J Pallen   +19 more
core   +1 more source